Ad
ACRS Stock - Aclaris Therapeutics Stock Trading
About | Aclaris Therapeutics Inc. (NASDAQ:ACRS)
Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two segments: therapeutics and contract research. The majority of its revenue comes from the contract research segment, which provides laboratory services. Its drug candidates under development are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138 is an ITJ Inhibitor; and ATI-1777.
Quote | Aclaris Therapeutics Inc. (NASDAQ:ACRS)
| Last: | $1.17 |
|---|---|
| Change Percent: | 0.85% |
| Open: | $1.17 |
| Close: | $1.17 |
| High: | $1.19 |
| Low: | $1.17 |
| Volume: | 161,577 |
| Last Trade Date Time: | 09/10/2024 03:00:00 am |
News | Aclaris Therapeutics Inc. (NASDAQ:ACRS)
-
WAYNE, Pa., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that members of the Aclaris management team will participate in a fire...
-
2024-08-07 09:17:59 ET More on Aclaris Therapeutics Aclaris sells OLUMIANT royalties and milestones to OMERS life sciences Seeking Alpha’s Quant Rating on Aclaris Therapeutics Historical earnings data for Aclaris Therapeutics Financial information for ...
Message Board Posts | Aclaris Therapeutics Inc. (NASDAQ:ACRS)
| Subject | By | Source | When |
|---|---|---|---|
| I was short premarket 20.30 then quickly covered | alchemytrader | investorshub | 01/20/2021 10:19:02 PM |
| ACRS offering more than 5m shares at $17.50/per share | SteevoTrader | investorshub | 01/20/2021 2:01:58 PM |
| The way she kept grinding back to 19s | alchemytrader | investorshub | 01/20/2021 4:50:21 AM |
| Are we seeing a dump tomorrow? | SteevoTrader | investorshub | 01/20/2021 1:57:36 AM |
| Oh really? hit 19.95 today... | alchemytrader | investorshub | 01/20/2021 12:55:29 AM |
News, Short Squeeze, Breakout and More Instantly...
Aclaris Therapeutics Inc. Company Name:
ACRS Stock Symbol:
NASDAQ Market:
Aclaris Therapeutics Inc. Website:
Ad
-
WAYNE, Pa., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that members of the Aclaris management team will participate in a fire...
-
-Initiated Phase 2a Study Activities for ATI-2138 in Atopic Dermatitis- -Strengthened Balance Sheet Through Sale of Future OLUMIANT ® Royalties for Proceeds of up to $31.5 Million- WAYNE, Pa., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), ...
-
BWX Technologies Inc. (BWXT) is expected to report $0.76 for Q2 2024 Banco Bradesco Sa American Depositary Shares (each representing one) (BBDO) is expected to report for Q2 2024 Federal Agricultural Mortgage Corporation (AGM) is expected to report $4.09 for Q2 2024 Ambac Financial Gr...
Important Investor News Alert (OTC: AABB)
-
LAS VEGAS, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce that the Company has been thrilled with the rise in gold and silver prices this year and the corresponding increases to AABB’s quarterly...